Squamous Cell Carcinoma Podcasts This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Genetic Profiling Identifies High-Risk Tumors in Cutaneous Squamous Cell Carcinoma
(Source: Medscape Transplantation Podcast)
Source: Medscape Transplantation Podcast - June 7, 2023 Category: Transplant Surgery Authors: Medscape 210869 Source Type: podcasts

JAMA Otolaryngology –Head & Neck Surgery : Use of Intraoperative Frozen Section Controls During Transoral Robotic Surgery for Oropharyngeal Cancer
Interview with Abie H. Mendelsohn, MD, author of Association of Intraoperative Frozen Section Controls With Improved Margin Assessment During Transoral Robotic Surgery for Human Papillomavirus–Positive Oropharyngeal Squamous Cell Carcinoma.Hosted by Paul C. Bryson, MD, MBA. (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - September 22, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts

JAMA Otolaryngology –Head & Neck Surgery : Use of Tumor Bed Frozen Section to Assess Final Tumor Margin in Oral Cavity Carcinoma
Interview with Snehal G. Patel, MD, author of Use of Intraoperative Frozen Section to Assess Final Tumor Margin Status in Patients Undergoing Surgery for Oral Cavity Squamous Cell Carcinoma. Hosted by Paul C. Bryson, MD, MBA. (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - August 4, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts

JAMA Oncology : Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma
Interview with David Anthony Palma, MD, PhD, and Anthony C. Nichols, MD, authors of Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical Trial Hosted by Jack West, MD. (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - April 28, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts

JAMA Otolaryngology –Head & Neck Surgery : Use of FDG-PET/CT to Predict Immunotherapy Treatment Response in Patients With OCSCC
Interview with Heather Jacene MD, and Jonathan D. Schoenfeld, MD, MPH, authors of Use of Fluoro-[F]-Deoxy-2-D-Glucose Positron Emission Tomography/Computed Tomography to Predict Immunotherapy Treatment Response in Patients With Squamous Cell Oral Cavity Cancers Hosted by Joseph P. Bradley, MD. (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - January 20, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts

JAMA Dermatology : Multiple vs First Incidence of Cutaneous Squamous Cell Carcinoma and Estimation of Future Incidences
Interview with Marlies Wakkee, MD, PhD, author of Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - October 28, 2020 Category: General Medicine Authors: The JAMA Network Source Type: podcasts

JAMA Otolaryngology –Head & Neck Surgery : Prognostic Case Volume Thresholds in Patients With Head and Neck Squamous Cell Carcinoma
Interview with Benjamin L. Judson, MD, author of Prognostic Case Volume Thresholds in Patients With Head and Neck Squamous Cell Carcinoma (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - June 13, 2019 Category: General Medicine Source Type: podcasts

Locally advanced cutaneous squamous cell carcinoma
Michael R. Migden, M.D., discusses locally advanced cutaneous squamous cell carcinoms. Background: Cemiplimab (REGN2810) produced substantial antitumor activity with durable responses in Phase 1 CS... Author: Annual-Meeting Added: 06/06/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 6, 2019 Category: Cancer & Oncology Source Type: podcasts

Primary analysis of Phase 2 results of cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with locally advanced cutaneous squamous cell carcinoma (laCSCC).
 Michael R. Migden, M.D., discusses the phase 2 results of Cemiplimab. Background: Cemiplimab (REGN2810) produced substantial antitumor activity with durable responses in Phase 1 CSCC expansion co... Author: Annual-Meeting Added: 06/06/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 6, 2019 Category: Cancer & Oncology Source Type: podcasts

Are There Therapies For Squamous Cell Carcinoma: PD-1 Inhibitor Approved For Metastatic Patients
Jessica Geiger MD Of The Cleveland Clinic Discusses Are There Therapies For Squamous Cell Carcinoma: PD-1 Inhibitor Approved For Metastatic Patients. Author: Annual-Meeting Added: 06/02/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 2, 2019 Category: Cancer & Oncology Source Type: podcasts

Photoimmunotherapy (PIT) Phase 2 Study: Multicenter, Open-Label, Study Of RM-1929 Photoimmunotherapy (PIT) In Patients With Locoregional, Recurrent Head & amp; Neck Squamous Cell Carcinoma (rHNSCC)
David M. Cognetti MD @KimmelCancerCtr Of Sidney Kimmel Cancer Center Discusses Photoimmunotherapy (PIT) Phase 2 Study: Multicenter, Open-Label, Study Of RM-1929 Photoimmunotherapy (PIT) In Patients Wi... Author: Annual-Meeting Added: 06/01/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 2, 2019 Category: Cancer & Oncology Source Type: podcasts

First-Line Therapy for Squamous Cell Lung Cancer Multiple Positive Trials from Various Combinations
Karen Reckamp, MD, MS Medical Director, Clinical Research Operations shares First-Line Therapy for Squamous Cell Lung Cancer Multiple Positive Trials from Various Combinations at the 2018 Oncology Su... Author: moasc Added: 03/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 7, 2018 Category: Cancer & Oncology Source Type: podcasts

Squamous Cell Carcinoma 4+ EGFR Carboplatin Cetuximab Safely or Bevacizumab
Roy S. Herbst, MD, PhD of Yale Cancer Center discusses squamous cell carcinoma 4+ EGFR and giving carboplatin cetuximab safely or bevacizumab. From the 22nd Annual Perspectives in Thoracic Oncology i... Author: thoraciconcology Added: 01/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 4, 2018 Category: Cancer & Oncology Source Type: podcasts

Squamous Cell Carcinoma Is There Hope?
Paul K. Paik, MD of Memorial Sloan Kettering Cancer Center discusses whether there is hope for squamous cell carcinoma. From the 22nd Annual Perspectives in Thoracic Oncology in New York <a target='_blank' href='http://imedex'>http://imedex...</a>... Author: thoraciconcology Added: 01/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 4, 2018 Category: Cancer & Oncology Source Type: podcasts

JAMA Dermatology : Fluorouracil for Prevention of Keratinocyte Carcinoma
Interview with Martin A. Weinstock, author of Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - January 3, 2018 Category: General Medicine Authors: The JAMA Network Source Type: podcasts